- Blog
- News & Media
- Issues
- About The Biopharmaceutical Sector
- Access and Affordability
- Adherence
- Appropriate Use Of Medicines
- Counterfeit Drugs
- Disaster Response
- Drug Safety
- Environmental Issues
- Food And Drug Administration
- Importation
- Intellectual Property
- International
- Medical Advances
- Medicare
- Prescription Drug Abuse
- Prescription Drug User Fee Act
- Sales And Marketing
- Value of Medicines
- Research
- About
PhRMA Chairman Chris Viehbacher on Biopharmaceutical Industry Mission, Access to Care, Part D
Chris Viehbacher, PhRMA's chairman and the CEO of Sanofi, was at our office the other day and took time for an interview with our camera crew. Watch this quick video to hear his thoughts about the value of new medicines, Medicare Part D, what inspires him each day, and what is "not only our mission, but our responsibility."



